# OnCo record stamp-merkel (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/stamp-merkel/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "stamp-merkel", "NCT03712605" ;
  schema:name "STAMP (EA6174)"@en ;
  schema:alternateName "STAMP"@en, "ECOG-ACRIN EA6174"@en ;
  schema:description "STAMP asks whether a year of pembrolizumab after surgery for Merkel cell carcinoma, a skin cancer that often comes back, prevents recurrence; it is one of two randomised trials testing adjuvant immunotherapy in this disease."@en ;
  schema:url <https://onco.cc/trials/stamp-merkel/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03712605> ;
  onco:status "active" ;
  onco:tag "subtype-trials" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/merkel-cell-carcinoma/>, <https://onco.cc/cancers/skin-cancer/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/> ;
  onco:people <https://onco.cc/people/shailender-bhatia/> .